Army researchers are exploring the benefits of immersive technology for warfighters. They have developed a platform to assess this technology called AURORA-MR.
The paper looks at the different benefits stars and non-stars bring, both to the task at hand and to the collaborators' ability to come up with breakthrough ideas in the future.
The more a company's board is independent from management, the less likely it will become entangled in corporate misconduct, according to new findings, from a meta-analysis of 135 studies, published in The Journal of Management. The site of independence also matters. Independence on the audit committee particularly shelters firms from misconduct, researchers found. At the same time, levels of corruption in countries where firms are located can overpower the effects of board independence on misconduct.
In a paper published Jan. 2 in PLOS Biology, two scientists at the University of Washington and North Carolina State University use the economic theory of contests to illustrate how the competitive grant-application system has made the pursuit of research funding inefficient and unsustainable -- and that alternative methods, such as a partial lottery to award grants, could relieve pressure on professors and free up time for research.
Less data-sharing among firms can actually lead to more collusion, economists find.
Using a series of auctions in which people were paid to close their accounts for as little as one day or as long as one year, a new study finds that Facebook users would require an average of more than $1,000 to deactivate their account for one year.
When it comes to personality, it turns out your peers probably think the same way about you as you do about yourself
When people in a business negotiation share not just a meal but a plate, they collaborate better and reach deals faster, according to new research from the University of Chicago Booth School of Business.
Immigrant academics play a critical role in the UK's international and national collaborations that bring social and economic benefits beyond academia, shows a new study of the public engagement activities of the UK's native-born and international academics.
Before TAILORx, there was uncertainty about treatment for women with hormone receptor-positive, HER2-negative, node-negative breast cancer and a score of 11-25 on a tumor gene test. The trial was designed to address this question and provides a definitive answer: no benefit from chemotherapy for women over 50 with a score of 11-25; 50 years old or younger with a score of 11-15; and any age with a score of 0-10.